Noam Zilberman is the current VP of Clinical Development at Laminate Medical. Noam has an in-depth background in the analysis and appropriate response to regulatory processes, laws, and regulations. Noam also has experience interfacing with relevant regulatory authorities including FDA, Health Canada, EU, European Non EU, and Taiwan. In addition, Noam has strategic thinking and work experience with cross-functional teams. Furthermore, they have experience and knowledge in the preparation of major and routine regulatory submissions as well as Vigilance program leadership.
Prior to their current position, Noam was a Regulatory Affairs Manager at Brainsgate from March 2013 to June 2015. Before that, they were a Clinical Trial Manager at Brainsgate from April 2010 to March 2013. In this role, they were responsible for international multicenter trial management including country and site feasibility assessment, patient recruitment management, clinical quality and data management, training clinical teams, agreements negotiation, and regulatory submissions. Prior to that, they were a Clinical Research Manager at Cato Research from May 2008 to April 2010. Before that, they were a CRA at Pharma-Clinical SAG from July 2006 to May 2008.
Noam Zilberman has a M.Sc in Molecular Genetics from The Hebrew University.
Noam Zilberman reports to Tammy Gilon, CEO & Co-Founder. Noam Zilberman works with Ran Agam - VP, Operations, Orit Yarden - VP, Clinical & Regulatory Affairs, and Oliver Baumgärtner - VP, Sales & Marketing.
View in org chart
View in org chart
VP, Clinical Development at Ionis Pharmaceuticals
VP, Clinical Development at Maxwell Group, Inc.
VP, Clinical Development at Engrail Therapeutics
VP, Clinical Development at Bexson Biomedical
VP, Clinical Development at Alzheon
VP, Clinical Development at Bright Peak Therapeutics